Poor responders to STN DBS in Parkinson’s disease: 1 year follow-up study
Objective: To determine which factors contribute to a poor outcome at 1 year after Deep Brain Stimulation (DBS) of the Subthalamic Nucleus (STN). Background: The…Could the rate of dopaminergic medications reduction affect outcome after STN-DBS?
Objective: A retrospective analysis of the rate of dopaminergic drugs reduction following subthalamic nucleus Deep Brain Stimulation (STN-DBS) in a group of Parkinson’s disease patients…Symptom specified target and procedure selection for Parkinson’s disease: A case report
Objective: To examine the clinical benefits and side effects of combined stereotactic surgery, namely ventralis intermedius (VIM) thalamotomy and bilateral asymmetric GPi/STN DBS, for Parkinson's…Biofabricated tissue constructs to recapitulate the anatomy and functionality of the nigrostriatal pathway in Parkinson’s disease
Objective: 1) Biofabricate constructs that mimic the cytoarchitecture and function of the nigrostriatal pathway, and 2) Microinject constructs to assess restoration of dopaminergic input to…Cortical and brainstem neurodegeneration associate with the clinical severity in spinocerebellar ataxia patients
Objective: The aim of the study was to know the association of degree of atrophy in brain areas with clinical severity in SCA patients. Background:…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.